300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Cryptocurrency
Social Impact
SaaS
Film
Restaurants
Photography
Email
Payments
CleanTech
Energy
Organic Food
Marketplace
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Renewable Energy
Software
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Theatre
Digital Media
FinTech
Medical
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Mexico
Nigeria
Russian Federation
Togo
Sweden
Zimbabwe
Zambia
Norway
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Tajikistan
Romania
Oman
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Japan
Ireland
Canada
South Africa
United Kingdom
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Parkview International, VC Fund

Parkview International

VC Fund

New York, United States

Parkview International is a VC fund in New York focused on Pet and Medical. Parkview International operates as a single-family office.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Parkview International invests in

PetMedicalVeterinaryHealth CareLife Science

Stages Parkview International invests in

Series ASeries C

Countries Parkview International invests in

AustraliaUnited States

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Investment Focus

Industry

  • Pet 1 (50%)
  • Medical 1 (50%)
  • Veterinary 1 (50%)
  • Health Care 1 (50%)
  • Life Science 1 (50%)
See all 7 industries →

Stage

  • Series A 1 (50%)
  • Series C 1 (50%)

Country

  • Australia 1 (50%)
  • United States 1 (50%)

Team

NameTitleInvestmentsLinksEmail
Steven Whitaker
Steven Whitaker President
President Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Petfolk Petfolk
Petfolk is a veterinary healthcare company that provides a connected community for today's vets, pets, and pet owners. It combines telehealth with brick-and-mortar and mobile clinics to make it easier for pet owners to book appointments and access follow-up care instructions without dealing with long wait times. It was launched in 2020 andis founded by vets with decades of experience in clinical practice. It is based in Charlotte, North Carolina. $36M / Series C / Oct 29, 2024
Proto Axiom Proto Axiom
Australia produces world leading intellectual property in drug development and medical equipment, yet captures virtually none of the downstream commercialisation and job multipliers. This is in part due to underdeveloped domestic preclinical expertise. Proto Axiom on shores this capacity, keeping Australian IP in Australia. $9.7M / Series A / Sep 27, 2022

Co-Investors

Catalio Capital Management Catalio Capital Management 2 deals together Churchill Asset Management Churchill Asset Management 1 deal together
Cutting Horse Cutting Horse 1 deal together
Deerfield Management Deerfield Management 1 deal together
HOF Capital HOF Capital 1 deal together
Idea Farm Ventures Idea Farm Ventures 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Cryptocurrency
Social Impact
SaaS
Film
Restaurants
Photography
Email
Payments
CleanTech
Energy
Organic Food
Marketplace
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Renewable Energy
Software
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Theatre
Digital Media
FinTech
Medical
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Mexico
Nigeria
Russian Federation
Togo
Sweden
Zimbabwe
Zambia
Norway
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Tajikistan
Romania
Oman
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Japan
Ireland
Canada
South Africa
United Kingdom
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Parkview International invest in?

Parkview International invests primarily in Pet, Medical and Veterinary startups, most often at Series A and Series C stage. Most of the 2 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Parkview International?

Public channels for Parkview International include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Parkview International?

The team at Parkview International includes Steven Whitaker (President). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Parkview International Parkview International Find emails